학술논문

Atorvastatin As Opposed To Ezetimibe Reduces Biomarkers Of Thrombosis In The Setting Of Aggressive Lipid Lowering Therapy: Findings From The American Heart Association Strategically Focused Cardiometabolic Health And Type 2 Diabetes Mellitus Research Network
Document Type
Journal
Source
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY; MAY 2022, 42 pA134 3p. Supplement: 1
Subject
Language
English
ISSN
15244636